Heterogeneity of health status treatment response with sacubitril/valsartan: insights from the CHAMP‐HF registry

Heterogeneity of health status treatment response with sacubitril/valsartan: insights from the CHAMP‐HF registry

Abstract Aims The aim of our study was to investigate heterogeneity of health status treatment response of sacubitril/valsartan in patients with heart failure with reduced ejection fraction (HFrEF). Methods and results We leveraged data from CHAMP‐HF, an observational registry of 140 US clinics and...

Full description

Bibliographic Details
Main Authors: Yevgeniy Khariton, Gregg C. Fonarow, Ann Hellkamp, Laine Thomas, Michael E. Nassif, Javed Butler, Carol I. Duffy, Nancy M. Albert, John A. Spertus
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:ESC Heart Failure
Subjects:
Chronic heart failure
Health status
Quality of life
Angiotensin‐neprilysin inhibitor
Online Access:https://doi.org/10.1002/ehf2.12981

Internet

https://doi.org/10.1002/ehf2.12981

Similar Items